Obesity does not adversely affect the outcome of laparoscopic antireflux surgery (LARS).

Department of Surgery, Washington University School of Medicine, Box 8109, St. Louis, MO 63110, USA.
Surgical Endoscopy (Impact Factor: 3.31). 12/2003; 17(12):2003-11. DOI: 10.1007/s00464-003-8118-9
Source: PubMed

ABSTRACT Because it has been suggested that obesity adversely affects the outcome of LARS, it is unclear how surgeons should counsel obese patients referred for antireflux surgery.
A prospective database of patients undergoing LARS from 1992 to 2001 was used to compare obese and nonobese patients. Patients were surveyed preoperatively and annually thereafter. Questionnaires were completed regarding global symptoms and overall satisfaction.
Of the 505 patients, the body mass index (BMI) was <25 (normal) in 16%, 25-29 (overweight) in 42%, and >30 (obese) in 42%. Although the operative time was longer in the obese group than in the normal weight group (137 +/- 55 min vs 115 +/- 42 min, p = 0.003), the time to discharge and rate of complications did not differ. At a mean follow-up of 35 +/- 25 months, there were no differences in symptoms, overall improvement, or patient satisfaction. Further, the rates of anatomic failure were similar among the obese, overweight, and normal weight groups.
Although the operative time is longer in the obese, complication and anatomic failure rates are similar to those in the nonobese at long-term follow-up. Obese patients have equivalent symptom relief and are equally satisfied postoperatively. Therefore, obesity should not be a contraindication to LARS.

  • [Show abstract] [Hide abstract]
    ABSTRACT: To determine the perioperative safety of esophageal fundoplication for gastroesophageal reflux disease (GERD) in patients with body mass index (BMI) ≥35 kg/m(2).
    The American Journal of Surgery 04/2014; · 2.41 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Obesity is a recognized risk factor for gastroesophageal reflux disease (GERD). Traditional antireflux surgery (fundoplication) may not be appropriate in the morbidly obese, especially when other effective alternatives exist (bariatric surgery). A 13-item survey was designed to elicit professional opinions regarding the treatment of medically refractory GERD in obese patients. Members of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) were randomly selected and emailed a link to an online survey. A total of 550 surgeons were contacted via email, and 92 (17 %) completed the survey. Of the respondents, 88 % perform laparoscopic antireflux surgery, 63 % perform bariatric surgery, and 59 % perform both. Overall, 77 % completed a minimally invasive surgery fellowship. In response to the question "Would you perform a laparoscopic fundoplication in a patient with medically refractory GERD and a BMI of 'X'?" surgeons were less likely to offer fundoplication at a higher body mass index (BMI). The majority of respondents felt that laparoscopic Roux-en-Y gastric bypass was the best option (91 %), followed by laparoscopic sleeve gastrectomy (6 %). Many had a morbidly obese patient with a primary surgical indication of GERD denied a bariatric procedure by their insurance company (57 %), and 35 % of those surgeons chose to do nothing rather than subject the patient to a fundoplication. Respondents uniformly felt that bariatric surgery should be recognized as a standard surgical option for treating GERD in the obese (96 %). When surgical treatment of GERD is indicated in an obese patient, bariatric surgery is the optimal approach, in the opinion of surgeons responding to our survey. Unfortunately, third-party payers often decline to provide benefits for a bariatric procedure for this indication. Additional data is necessary to confirm our belief that the opinions elicited through this survey are consistent with the standard of care as defined by the medical community.
    Surgical Endoscopy 12/2013; · 3.31 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Laparoscopic antireflux surgery is a widely used and effective option in the properly selected patient with gastroesophageal reflux disease. Poor symptomatic outcomes occur even in the best of hands, the most common being recurrent or persistent heartburn (or atypical symptoms) and dysphagia. When heartburn predominates, anatomic and physiologic evaluation is needed to determine whether acid reflux is controlled and if the postoperative neoanatomy is appropriate. Dysphagia in the immediate postoperative setting mandates reassurance, as conservative measures alone often suffice. With persistent dysphagia, anatomic and physiologic evaluation again is indicated in search of a mechanical, motility, or reflux-related symptom basis. Reoperation carries substantial morbidity and reduced success rates when compared with the initial procedure, mandating careful patient selection and referral to a center with thorough surgical experience in these procedures.
    Current GERD Reports 01/2007; 1(1):41-49.